Wei Zhu

发表

Diagnostic value of ACTH stimulation test in determining the subtypes of primary aldosteronism.

J. Xie, G. Ning, Weiqing Wang, 2015, The Journal of clinical endocrinology and metabolism.

The genetic landscape of benign thyroid nodules revealed by whole exome and transcriptome sequencing

Weiqing Wang, G. Ning, Yulin Zhou, 2017, Nature Communications.

Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease.

G. Ning, Huai-Dong Song, B. Cui, 2010, Clinical endocrinology.

Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9, and IL-13 with Graves’ disease

G. Ning, B. Cui, Yong-ju Zhao, 2010, Journal of endocrinological investigation.

Smoking was associated with poor response to intravenous steroids therapy in Graves’ ophthalmopathy

Weiqing Wang, G. Ning, Qin Jiao, 2015, British Journal of Ophthalmology.

Relationships between serum levels of thyroid hormones and serum concentrations of asymmetric dimethylarginine (ADMA) and N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patients with Graves’ disease

Lin Zhao, G. Ning, Feng-ying Li, 2011, Endocrine.

Genetic association between Interleukin‐17A gene polymorphisms and the pathogenesis of Graves’ disease in the Han Chinese population

G. Ning, Shu Wang, B. Cui, 2016, Clinical endocrinology.

Clinical features and prognosis of thymic neuroendocrine tumours associated with multiple endocrine neoplasia type 1: A single‐centre study, systematic review and meta‐analysis

Weiqing Wang, G. Ning, Yulin Zhou, 2017, Clinical endocrinology.

Genetic association between IL-17F gene polymorphisms and the pathogenesis of Graves' Disease in the Han Chinese population.

G. Ning, Y. Huo, Changqin Liu, 2013, Gene.

Methotrexate plus reduced or full-dose glucocorticoids for the treatment of active, moderate-to-severe Graves’ orbitopathy

Weiqing Wang, Yulin Zhou, Qin Jiao, 2022, European thyroid journal.

Both interleukin-23A polymorphism and serum interlukin-23 expression are associated with Graves' disease risk.

G. Ning, Changqin Liu, Shu Wang, 2015, Cellular immunology.

A prospective, randomized trial of intravenous glucocorticoids therapy with different protocols for patients with graves' ophthalmopathy.

Weiqing Wang, G. Ning, Qin Jiao, 2014, The Journal of clinical endocrinology and metabolism.

Circulating microRNA predicts insensitivity to glucocorticoid therapy in Graves’ ophthalmopathy

Weiqing Wang, G. Ning, Shu Wang, 2015, Endocrine.

Intensive insulin therapy combined with metformin is associated with reduction in both glucose variability and nocturnal hypoglycaemia in patients with type 2 diabetes

Weiqing Wang, G. Ning, Zhiyun Zhao, 2017, Diabetes/metabolism research and reviews.

Tumor necrosis factor alpha (TNF-alpha) polymorphisms in Chinese patients with Graves' disease.

Lin Zhao, G. Ning, Jian-min Liu, 2010, Clinical biochemistry.

Differential microRNA expression in peripheral blood mononuclear cells from Graves' disease patients.

G. Ning, Shu Wang, B. Cui, 2012, The Journal of clinical endocrinology and metabolism.

ROLE OF MAGNETIC RESONANCE IMAGING IN THE ASSESSMENT OF ACTIVE THYROID-ASSOCIATED OPHTHALMOPATHY PATIENTS WITH LONG DISEASE DURATION.

Weiqing Wang, Yulin Zhou, Qin Jiao, 2019, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Genetic association between IL-17F gene polymorphisms and the pathogenesis of Graves' Disease in the Han Chinese population.

G. Ning, Y. Huo, Changqin Liu, 2013, Gene.